期刊文献+

慢性乙型肝炎患者肝组织FasL表达与血清可溶性FasL水平的关系 被引量:4

The relationship between the expression of FasL and serum levels of soluble FasL in patients with chronic hepatitis B
下载PDF
导出
摘要 目的 探讨慢性乙型肝炎患者肝组织中FasL表达与血清可溶性FasL水平的关系。方法 用免疫组化方法检测 60例慢性乙型肝炎患者肝穿组织FasL的表达 ,同时用酶联免疫吸附试验检测血清可溶性FasL。结果 重度慢性乙型肝炎患者血清中sFasL水平 >中度 >轻度 ,各组间差异有显著意义 (P <0 0 1 ) ;慢性乙型肝炎患者肝组织FasL表达的程度和血清sFasL水平与肝组织病变的活动性一致。结论  (1 )肝组织炎症程度加重 ,肝组织FasL抗原的表达增强 ,同时血清中sFasL水平升高 ;(2 )Fas介导的肝细胞凋亡在慢性乙型肝炎的发病机制中起重要作用 。 Objective To explore the relationship between the expression of FasL and serum levels of soluble fasL in patients with chronic hepatitis B.Methods liver biopsies were studied by immunohistochemistry to determine FasL and serum levels of soluble FasL(sFasL)were detected with ELISA in 60 patients with chronic hepatitis B.Results sFasL levels in patients with chronic hepatitis B were severe>moderate>mild, there was significant difference among the three groops ( P <0 01),the histological activity index was correlated with the degree of expression of fasL and the serum levels of sFasL( P <0 01).Conclusion (1)There was a correlationship betweem the expression of FasL antigen in liver tissue、the serum sFasL levels and histological activity;(2) The hepatic apotosis mediated through Fas antigen may play an important role in pathogenesis of chronic hepatitis B, decreasing Fas expression contribute to alleviate the degree of hepatic injury.
机构地区 解放军
出处 《重庆医学》 CAS CSCD 2001年第6期528-529,共2页 Chongqing medicine
基金 福建省漳州市科委基金资助项目 (Z0 0 2 7)
关键词 慢性乙型肝炎 FASL 可溶性FASL 肝组织 chronic hepatitis B FasL soluble FasL
  • 相关文献

参考文献3

二级参考文献5

  • 1[1] Mochizuki K, Hayashi N, Hiramatsu N, et al. Fas antigen expression in liver tissue of patients with chronic hepatitis B J Hepatology,1996, 24:1.
  • 2[2] Knodell RG, Ishak KG, Black WC, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology, 1981, 1:431.
  • 3[3] Mira E, Hayashi N. Apoptosis in human disease: role of Fas system in liver cell injury by viral hepatitis. Rinsho Byori, 1997, 45: 477.
  • 4[4] Hodgson PD, Grant MD, Michalak TI. Perforin and Fas/Fas ligandmediated cytotoxicity in acute and chronic woodchuck viral hepatitis. Clin Exp Immunol, 1999, 118:63.
  • 5郑瑞丹,饶日春,徐忠玉,杨铮.慢性乙型肝炎患者血清sCD14的水平与肠源性内毒素血症的关系[J].第一军医大学学报,2000,20(5):406-407. 被引量:4

共引文献1768

同被引文献30

  • 1林向阳,吴娅娅,陶志华,陈晓东,沈关心,吴健民.肝硬化、肝癌患者血清sFas和TGF-β_1水平的探讨[J].中国实验诊断学,2005,9(1):102-104. 被引量:3
  • 2林向阳,陈艳,陶志华,陈晓东,沈关心,吴健民.重症乙型肝炎患者血清中可溶性Fas和可溶性FasL水平的检测[J].中华医院感染学杂志,2005,15(11):1227-1229. 被引量:1
  • 3饶慧瑛,郭芳,魏来.2005年美国肝病学会急性肝衰竭诊治和肝移植患者评价指南简介[J].中华肝脏病杂志,2006,14(2):154-156. 被引量:22
  • 4Kagi D, Vignaux F,Ledermann B,et al. Fas and perforin pathways as major mechanisms of T cell - mediated cytotoxity. Science, 1994,265(22):528
  • 5Taieb M, Mathurin P, Poynard T, et al. Raised plasma soluble Fas and Fas- ligand in alcoholic liver disease. The Lancet, 1998,351 (27):1930
  • 6金惠铭.病理生理学[M].北京:人民卫生出版社,1998..
  • 7Hengartner MO.The biochemistry of apoptosis,Nature,2000,407( ):770-775.
  • 8Bari R,Bedi A.Requirement of BAX for TRAIL/apo2L-induced apoptosis of colorectal cancers:synergism with sulindac-mediated inhibition of BclXL.Cancer Res,2002,62(6):1583-1587.
  • 9Greenstein S,Chias K,Krett NL.et al.Mechanisms of glucocorticoidmediated apoptosis in hematological malignancies.Clin Cancer Res,2002,8(6):1681-1694.
  • 10Knodell RG,Ishak KG,Black WC,et al.Formalation and application of a Numercal scoring system for assessing histological activity in asymptomatic chronic active hepatitis.Hepatology,1981,1(5):431-435.

引证文献4

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部